spacer Login | Register
THEMES: BIOTECH EQUIPMENT | BIOTECH RESEARCH | BIOTECH DIAGNOSIS

Vanda Pharmaceuticals' Insomnia Drug Registers Positive Results

Related Stocks: VNDA

H.S. Ayoub submits: Vanda Pharmaceuticals Inc (VNDA) announced early Wednesday that its insomnia drug, VEC-162, showed positive results in a phase III clinical trial. The drug met many endpoints, and had a statistically significant difference in inducing and maintaining sleep compared to placebo.

Complete Story » Comment Here

Elbit Medical: A Biotech Entrepreneur that Deserves a Closer Look

Related Stocks: EMITF

spacer Shlomo Greenberg submits: Elbit Medical Imaging (EMITF) published its Q2 report at the beginning of September, and the less said about it the better. The company’s loss grew, shareholder equity narrowed, and financing expenses increased substantially. But since that report was published, the stock has climbed 40%.

Complete Story » Comment Here

Illumina Acquires Solexa, Hopes To Make Human Genetic Mapping Faster and Cheaper

Related Stocks: ILMN, SLXA

spacer Jonathan Liss submits: Excerpt from our Wall Street Breakfast, a one-page summary of this morning's key market-moving and stock-moving stories:

Complete Story » Comment Here

Biotech Holiday Shopping: Solexa, Tanox and KOS Bought Out

Related Stocks: ABT, DNA, ILMN, KOSP, SLXA, TNOX

H.S. Ayoub submits: Shares of gene analysis systems maker Solexa Inc (SLXA) jumped 30% on Monday as Illumina Inc (ILMN) offered $600 million in stock for stock swap merger agreement.

Complete Story » Comment Here

Nabi Bipharmaceuticals Finally Buckles: Activist Shareholders to Join Board

Related Stocks: NABI

spacer Lon Juricic submits: This morning, Nabi Biopharmaceuticals (NABI) and dissident shareholder Third Point LLC announced that they have reached a settlement relating to a potential consent solicitation.

Complete Story » Comment Here
Monday, November 13th, 2006
Genentech's Tanox Buyout And Earnings Potential
by Chad Brand with stocks: DNA, TNOX
Sunday, November 12th, 2006
Elron: Discount Access to Future Biotech Leaders
by Shlomo Greenberg with stocks: ELRN
Friday, November 10th, 2006
Genetech to Acquire Xolair Co-developer Tanox for $919 Million
by Eli Hoffmann with stocks: DNA, NVS, TNOX
Thursday, November 9th, 2006
Thermogenesis Corp. Doubles Revenue, Cuts Loss
by H.S. Ayoub with stocks: KOOL
Wednesday, November 8th, 2006
Why Doesn't Biogen Idec Just Buy Out Targeted Genetics?
by H.S. Ayoub with stocks: BIIB, TGEN
Tuesday, November 7th, 2006
Teva Pharmaceuticals Q3 2006 Earnings Call Transcript
with stocks: TEVA
Friday, November 3rd, 2006
PDL BioPharma Q3 2006 Earnings Call Transcript
with stocks: PDLI
Cephalon Q3 2006 Earnings Call Transcript
with stocks: CEPH
Wednesday, November 1st, 2006
Gen-Probe Q3 2006 Earnings Call Transcript
with stocks: GPRO
BioMarin Recieves Approval for Aldurazyme in Japan
by H.S. Ayoub with stocks: BMRN
Charles River Laboratories: Driving The Rat Race
by James Hale with stocks: CRL
Tuesday, October 31st, 2006
Biogen Idec Q3 2006 Earnings Call Transcript
with stocks: BIIB
Monday, October 30th, 2006
Insite Vision Trades Up 17% on No News
by H.S. Ayoub with stocks: ISV
Sunday, October 29th, 2006
Invitrogen Falls Hard on Earnings Miss
by H.S. Ayoub with stocks: IVGN
Thursday, October 26th, 2006
Biosite Q3 2006 Earnings Call Transcript
with stocks: BSTE
Vertex Pharmaceuticals Q3 2006 Earnings Call Transcript
with stocks: VRTX
Celgene Q3 2006 Earnings Call Transcript
with stocks: CELG
MedImmune Q3 2006 Earnings Call Transcript
with stocks: MEDI
Millennium Pharmaceuticals Q3 2006 Earnings Call Transcript
Cytyc Buys New Device; Q3 Results Promising
by H.S. Ayoub with stocks: CYTC
Wednesday, October 25th, 2006
Affymetrix Q3 2006 Earnings Call Transcript
with stocks: AFFX
Dupont Reports Profit After Hurricane Woes
by Miriam Metzinger with stocks: DD
H&Q Life Sciences: A Compelling Healthcare CEF
by H.S. Ayoub with stocks: HQH, HQL
Isolagen: After Meeting Managment, We're Still Upbeat
by Envoy Global Research with stocks: ILE
Tuesday, October 24th, 2006
Amgen Q3 2006 Earnings Call Transcript
with stocks: AMGN
Thursday, October 19th, 2006
SIGA Shares Double on Smallpox Drug News
by H.S. Ayoub with stocks: SIGA
Does Keryx Biopharmaceuticals Deserve Its Valuation?
by Shlomo Greenberg with stocks: KERX, TEVA
Wednesday, October 18th, 2006
HIV and Flu Drive Growth at Gilead
by Evelyn Rubin with stocks: GILD
Gilead Q3 2006 Earnings Call Transcript
with stocks: GILD
Tuesday, October 17th, 2006
Nabi Biopharm Holder Third Point To Pursue Consent Solicitation Toward Ousting Directors
by Lon Juricic with stocks: NABI
Millenium Ends Its Bid For AnorMED, Leaving Genzyme On Top
by H.S. Ayoub with stocks: ANOR, GENZ, MLNM
Monday, October 16th, 2006
New Leadership Makes Isolagen Attractive
by Envoy Global Research with stocks: ILE
Thursday, October 12th, 2006
Genzyme Q3 2006 Earnings Call Transcript
with stocks: GENZ
Wednesday, October 11th, 2006
Monsanto F4Q06 (Qtr End 8/31/06) Earnings Call Transcript
with stocks: MON
Nabi Biopharm's Activist Holder Wants Chaiman Ousted
by Lon Juricic with stocks: NABI
« Previous Entries

RESEARCH STOCKS

Type in a stock or ETF symbol to get:

  • Opinion and analysis
  • Earnings call transcripts
  • Quote and chart

TRANSCRIPTS »

  • Teva Pharmaceuticals Q3 2006 Earnings Call Transcript
gipoco.com is neither affiliated with the authors of this page nor responsible for its contents. This is a safe-cache copy of the original web site.